![Joseph Gilliam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Gilliam
Presidente presso
GLAUKOS CORPORATION
Patrimonio netto: 8 M $ in data 31/05/2026
Profilo
Joseph E.
Gilliam is currently Independent Director at Caris Life Sciences, Inc. since 2021, Director at Avedro, Inc. since 2019, and President & Chief Operating Officer at Glaukos Corp.
since 2022.
Formerly, Mr. Gilliam was Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2013 to 2017.
Mr. Gilliam completed undergraduate studies at Kelley School of Business in 1998.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GLAUKOS CORP 0,13% | 01/05/2026 | 73.419 ( 0,13% ) | 8 M $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Joseph Gilliam
| Società | Posizione | Inizio |
|---|---|---|
| GLAUKOS CORPORATION | Presidente | 01/04/2022 |
| AVEDRO, INC. | Direttore/Membro del Consiglio | 21/11/2019 |
| CARIS LIFE SCIENCES, INC. | Direttore/Membro del Consiglio | 01/04/2021 |
Precedenti posizioni note di Joseph Gilliam
| Società | Posizione | Fine |
|---|---|---|
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/05/2017 |
Formazione di Joseph Gilliam
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Glaukos Corp.
 Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Caris Life Sciences, LLC
 Caris Life Sciences, LLC BiotechnologyHealth Technology Operates as an AI-powered biotech company that provides molecular profiling services to develop oncology pharmaceuticals with proprietary platform | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
